Printer Friendly
The Free Library
21,415,176 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Browse Diagnostic reagents industry topic

 

Articles

1-300 out of 600 article(s) nextnext page
Title Author Type Date Words
Sigma-Aldrich Corporation Declares $0.215 Per Share Quarterly Dividend. May 7, 2013 251
Sigma-Aldrich Corporation Announces Webcasts of Annual Shareholders Meeting and Participation at Investor Conferences. Conference news Apr 30, 2013 455
Chaos in hospital's lab deal. Apr 27, 2013 266
Malaria No More Announces Innovative Partners For Its 'Power Of One' Malaria Campaign. Apr 25, 2013 996
North American Nuclear Medicine/Radiopharmaceuticals & Stable Isotopes Market [SPECT/PET Radioisotopes (Technetium, F-18)], [Beta/Alpha Radiation Therapy (I131, Y-90)], [Applications (Cancer/Oncology, Cardiac)] & (Deuterium, C-13) - Forecast to 2017. Apr 22, 2013 4245
Before the Bell Scans of Agilent Technologies, Thermo Fisher Scientific, PerkinElmer, Laboratory Corp. of America, and Alere. Apr 22, 2013 850
European Nuclear Medicine / Radiopharmaceuticals Market [SPECT/PET Radioisotopes (Technetium, F-18)], [Beta/Alpha Radiation Therapy (I131, Y-90)], [Applications (Cancer/Oncology, Cardiac)] & Stable Isotopes (Deuterium, C-13) - Global Trends & Forecast to. Apr 10, 2013 4277
Quidel and Life Technologies Receive FDA Clearance for Clostridium difficile Assay and QuantStudio(TM) Dx and 7500 Fast Dx Real-Time PCR Instruments. Mar 18, 2013 2007
Global Cell/Tissue Culture Supplies Industry. Mar 14, 2013 4366
Lantheus Medical Imaging Announces Appointment of Cesare Orlandi, M.D., as New Chief Medical Officer. Mar 6, 2013 735
DiagnosisOne Unveils New Name, Alere Analytics, at the Healthcare Information Management Systems Society (HIMSS) 2013 Annual Conference. Mar 4, 2013 813
In-Vitro Diagnostics Market Analysis to 2017. Feb 19, 2013 2120
Lantheus Medical Imaging Announces FDA Approval of Jubilant HollisterStier as a New Manufacturing Site for DEFINITY[R]. Feb 11, 2013 993
Viracor-IBT Labs acquires assets of Cylex; includes it's core product ImmuKnow. Feb 1, 2013 120
Lantheus Medical Imaging Announces Appointment of Jeffrey A. Bailey as New Chief Executive Officer. Jan 24, 2013 826
Asia-Pacific In Vitro Diagnostics Market Outlook to 2018- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture. Industry overview Jan 23, 2013 4946
Infectious Immunology Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018. Industry overview Jan 23, 2013 5238
Contrast Media/Contrast Agents Market By Product (Iodinated, Gadolinium & Barium), By Technique (X-ray, CT, MRI, Cath Lab & Ultrasound) & By Application (Radiology, Interventional Radiology & Interventional Cardiology) - Global Trends & Forecast to 2017. Jan 14, 2013 4406
Lantheus Medical Imaging Introduces Low-Enriched Uranium (LEU) TechneLite Generator. Jan 9, 2013 1484
Lantheus Medical Imaging and FUJIFILM RI Pharma Renew Long-Term License and Distribution Agreement for Cardiolite and Neurolite in Japan. Jan 3, 2013 1380
Advaxis Appoints Daniel J. O'Connor to Senior Vice President, Chief Legal and Business Development Officer. Jan 3, 2013 866
The Gores Group Completes the Acquisition of Therakos, Inc. from Ortho-Clinical Diagnostics, Inc. Jan 2, 2013 544
Roche and PSS Sign Agreement to Develop a Fully Automated Workflow Solution for Next-generation Sequencing Platforms. Dec 21, 2012 719
Roche and PSS Sign Agreement to Develop a Fully Automated Workflow Solution for Next-generation Sequencing Platforms. Dec 21, 2012 725
Hospitals, Healthcare Providers to Benefit from New Multi-Source Premier Agreements for Blood Bank Analyzers, Reagents, Consumables and Service. Dec 19, 2012 236
North America In Vitro Diagnostics Market Outlook to 2018- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture. Industry overview Dec 17, 2012 3666
Sabre Holdings Executive Honored with 'Superstar Award' From Institute for Healthcare Consumerism. Dec 11, 2012 812
Global Proteomics Industry. Dec 5, 2012 3567
Global Cell/Tissue Culture Supplies Industry. Nov 29, 2012 5202
Alere Wellogic Showcases "Meaningful Use" for Radiologists at RSNA 2012. Nov 29, 2012 616
Immunetics, Inc. Names John Yonkin as CEO. Nov 26, 2012 541
Blueprint Medicines Welcomes Daniel S. Lynch to its Board of Directors as Executive Chairman; Announces Permanent Appointment of Chris Varma, Ph.D., as Chief Executive Officer. Nov 13, 2012 868
Lantheus Medical Imaging to Host Third Quarter 2012 Conference Call on November 13, 2012 at 4:00 P.M. Eastern Time. Nov 7, 2012 368
Agilent Technologies and Roche Establish Agreement to Provide Continued Service and Support to Roche NimbleGen Microarray Customers. Nov 7, 2012 576
Germany : Roche launches new Light Cycler 96 System enabling broad application of its high-performance PCR technology in academic research. Brief article Nov 7, 2012 298
PDL BioPharma Completes Royalty Transaction with Wellstat Diagnostics. Nov 5, 2012 1261
Lantheus Medical Imaging Extends Contract with NTP Radioisotopes to Ensure Robust Supply of LEU-Produced Molybdenum-99. Oct 31, 2012 1631
MedVirginia Extends Health Information Exchange Contract with Alere Wellogic. Oct 24, 2012 779
Nordion Extends Molybdenum-99 Supply Contract with Lantheus Medical Imaging, Inc. through 2015. Oct 22, 2012 691
Lantheus Medical Imaging and Nordion Extend Molybdenum-99 Supply Contract Through 2015. Oct 22, 2012 829
Laboratory Corporation of America[R] Holdings Announces 2012 Third Quarter Results. Financial report Oct 18, 2012 9183
The Gores Group Extends Binding Offer to Acquire Therakos, Inc. from Ortho-Clinical Diagnostics, Inc. Oct 15, 2012 552
Groundbreaking study shows that a simple, rapid PlGF test can accurately risk stratify pregnant women with suspected pre-eclampsia(1). Oct 8, 2012 870
Alere Partners with Spina Bifida Association to Sponsor Education During October, Spina Bifida Awareness Month. Oct 3, 2012 610
Bio-Pharma Company, Sigma-Aldrich, Invests in Scotland. Sep 28, 2012 621
BIND Biosciences Appoints Industry Veteran Daniel Lynch as Chairman of the Board of Directors. Sep 20, 2012 753
Lantheus Medical Imaging to Present at Imperial Capital Global Opportunities Conference on September 20, 2012. Conference news Sep 13, 2012 345
United States : Lantheus MI Holdings, Inc. Appoints Brian A. Markison to its Board of Directors. Sep 11, 2012 398
Lantheus MI Holdings, Inc. Appoints Brian A. Markison to its Board of Directors. Sep 10, 2012 753
Research and Markets: Alere Inc. - Strategy and SWOT Report. Sep 7, 2012 561
Global Medical Laboratories Industry. Company overview Sep 5, 2012 6664
Merriman Capital Adds Health Care Investment Banker David Sans, Ph.D. To Financial Entrepreneur Platform. Sep 5, 2012 780
InGen BioSciences Group, Announced Comprehensive Offering of in vitro Diagnostics in France With the Signature of Exclusive Distribution Partnerships With Quidel and Diagnostic Hybrids. Company overview Aug 19, 2012 1190
Personalized Medicine - A Global Market Overview. Industry overview Aug 16, 2012 4322
Lantheus Medical Imaging to Host Second Quarter 2012 Conference Call on August 16, 2012 at 4:00 P.M. Eastern Time. Aug 10, 2012 368
Global Chiral Technology Industry. Aug 9, 2012 4192
LabCorp Completes Acquisition of MEDTOX. Aug 1, 2012 481
Critical Diagnostics Adds Two More IVD Industry Veterans. Aug 1, 2012 321
SynenTec to Take Over Roche Cellavista System. Jul 31, 2012 492
Biotechnology Reagents Market by Technology (PCR, Cell Culture, Expression & Transfection, Chromatography, Mass Spectrometry, Electrophoresis, & Flow Cytometry), Applications (Protein Purification, Gene Expression, DNA & RNA Analysis, & Drug Testing) and. Company overview Jul 26, 2012 4880
Research and Markets: Poland In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2017. Jul 25, 2012 495
Sangamo BioSciences Reports Second Quarter 2012 Financial Results. Financial report Jul 25, 2012 3740
Alere to Launch Maternity and NICU Care Management Programs For Texas Medicaid Fee-for-Service Clients. Jul 9, 2012 484
Global Clinical Diagnostics Automation Industry. Jul 3, 2012 3452
Global Angiogenesis Inhibitors and Stimulators Industry. Jul 3, 2012 5059
Global Immunoassay Systems Industry. Jul 3, 2012 5850
The five FDA-approved HPV assays. Jul 1, 2012 2432
Clinical Chemistry Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017. Industry overview Jun 27, 2012 3827
AHIP's Institute 2012: "Make Connected Care a Reality," Says Alere Health's Dr. Gordon Norman. Jun 20, 2012 708
Lantheus Selected to Receive $300,000 Massachusetts-Israel Innovation Partnership Grant. Jun 19, 2012 819
Law Office of Brodsky & Smith, LLC Announces Investigation of MEDTOX Scientific, Inc. Jun 16, 2012 323
InGen BioSciences Group, Exclusive Distributor for Cylex Incorporated in France, Reinforces its Translational Medicine Positioning. Jun 14, 2012 1647
Law Office of Brodsky & Smith, LLC Announces Investigation of MEDTOX Scientific, Inc. Jun 9, 2012 323
National Committee for Quality Assurance Grants "Accredited with Performance Reporting" Status to Alere. Jun 6, 2012 533
Ryan & Maniskas, LLP Announces Investigation of MEDTOX Scientific Inc. Jun 5, 2012 317
The Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of MEDTOX Scientific, Inc. in Connection with the Sale of the Company to Laboratory Corporation of America[R] Holdings. Jun 5, 2012 368
MEDTOX Scientific, Inc. Is Investigated by Faruqi & Faruqi, LLP for Potential Breaches of Fiduciary Duties by Its Board of Directors. Jun 5, 2012 377
LabCorp Announces Agreement to Acquire MEDTOX Scientific. Jun 4, 2012 1151
Pomerantz Law Firm Investigates Claims on Behalf of Investors of Medtox Scientific, Inc. Jun 4, 2012 268
The Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of MEDTOX Scientific, Inc. in Connection with the Sale of the Company to Laboratory Corporation of America[R] Holdings. Jun 4, 2012 333
Rigrodsky & Long, P.A. Announces Investigation Of Medtox Scientific, Inc. Buyout. Jun 4, 2012 333
Robbins Umeda LLP Announces an Investigation of MEDTOX Scientific, Inc. Jun 4, 2012 555
MEDTOX Scientific, Inc. Buyout Investigated by the Securities Attorneys at The Briscoe Law Firm and Powers Taylor, LLP. Jun 4, 2012 354
Lantheus Medical Imaging to Present at Jefferies 2012 Global Healthcare Conference. Company overview May 31, 2012 324
In Vitro Diagnostics Market to 2018 - Consolidation, Decentralization and Demand for Genetic Testing to Shape the Competitive Landscape. May 30, 2012 4525
Biosensors - A Global Market Overview. May 22, 2012 4277
Lantheus Appoints New Member to Its Board of Directors. May 17, 2012 715
Lantheus Medical Imaging to Host First Quarter 2012 Conference Call on May 23, 2012 at 4:00 p.m. Eastern Time. May 17, 2012 368
In-Vitro Diagnostics (IVD) Market (Clinical Chemistry, Immunoassays, Molecular Diagnostics, Hematology Analyzers & Microbiology Culture) - Global Trends & Forecasts to 2016. May 9, 2012 3350
Largest Study of Its Kind Shows That Health Plans and Physicians Need to Do More to Combat Nausea and Vomiting During Pregnancy. Report May 7, 2012 985
Lantheus Medical Imaging Announces Appointment of Alexander E. Kuta, Ph.D., as Vice President, Global Regulatory Affairs and Nigel Williams as Vice President, Quality. May 3, 2012 701
Research and Markets: Hungary In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2017. Apr 30, 2012 408
Making Connected Health a Reality. Apr 24, 2012 918
IntegenX Acquires DNA Consumable Portfolio From GE Healthcare. Apr 23, 2012 535
University of Illinois at Urbana-Champaign Announces Licensing Agreement with Sigma-Aldrich to Provide Membrane Scaffold Proteins for Nanodisc Technology to the Research Community. Apr 19, 2012 639
Alere Health CEO Mike Cotton Gives Opening Remarks at 9th Annual World Health Care Congress. Apr 16, 2012 724
Research and Markets: Australia In Vitro Diagnostics Market Outlook to 2017. Apr 11, 2012 414
Research and Markets: In Vitro Diagnostics Market to 2018 - Consolidation, Decentralization and Demand for Genetic Testing to Shape the Competitive Landscape. Apr 5, 2012 400
Lantheus Medical Imaging to Host Fourth Quarter/2011 Conference Call on April 5, 2012 at 4:00 p.m. Eastern Time. Mar 29, 2012 371
Avioq Receives FDA Approval for HTLV-I/II Microelisa System. Mar 28, 2012 688
In Vitro Diagnostics Market to 2018 - Consolidation, Decentralization and Demand for Genetic Testing to Shape the Competitive Landscape. Mar 28, 2012 4522
Alere Offers New At-Home BP Monitoring Program For CAD Participants. Feb 29, 2012 497
Alere to Acquire eScreen, Inc. Feb 28, 2012 461
Lantheus Medical Imaging Announces Strategic Relationship with Beijing Double-Crane Pharmaceuticals for the Distribution and Supply of DEFINITY[R] in China. Feb 23, 2012 1228
Lantheus Medical Imaging to Present at Upcoming Investor Conferences. Company overview Feb 21, 2012 526
Research and Markets: Italy In Vitro Diagnostics Market Outlook to 2017. Industry overview Feb 16, 2012 427
Research and Markets: South Africa In Vitro Diagnostics Market Outlook to 2017. Feb 14, 2012 551
Research and Markets: Greece In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2017. Feb 14, 2012 432
Research and Markets: Sweden In Vitro Diagnostics Market Outlook to 2017. Feb 14, 2012 417
Research and Markets: Switzerland In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2017. Feb 14, 2012 385
Global Nuclear Medicine (Medical Isotopes/Radioisotopes/Radiopharmaceuticals) Market in PET/SPECT Imaging & Therapy - Competitive Landscape, Current Trends & Forecasts (2010-2015). Feb 9, 2012 4468
Sangamo BioSciences Reports Fourth Quarter and Full Year 2011 Financial Results. Financial report Feb 8, 2012 4435
Microbiology Culture Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017. Industry overview Jan 24, 2012 5146
United States In Vitro Diagnostics Market Outlook to 2017 - Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture. Industry overview Jan 24, 2012 5815
North America In Vitro Diagnostics Market Outlook to 2017 - Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture. Industry overview Jan 23, 2012 4251
Counsel for Former Matria Healthcare Chairman and CEO Parker H. Petit Deny SEC Claims. Jan 11, 2012 1112
Sandata Technologies Names Tom Underwood CEO. Jan 9, 2012 782
Avista Capital Partners Agrees to Sell BioReliance to Sigma-Aldrich Corporation. Jan 9, 2012 732
Lantheus Medical Imaging Announces Chief Financial Officer Robert Gaffey to Retire. Company overview Jan 4, 2012 576
US and European Radiopharmaceuticals Industry. Dec 12, 2011 5678
Global Automated and Rapid Microbiological Tests Industry. Company overview Dec 8, 2011 8151
Alere partners with global health nonprofit PSI to donate up to one million HIV tests. Dec 1, 2011 693
Palm Beach Capital Announces Divestiture of Arriva Medical. Company overview Nov 30, 2011 258
Redwood Toxicology Laboratory Expands Testing for Synthetic Cannabinoids to Cover New "Legal" Highs. Nov 22, 2011 594
Hospitals, Healthcare Providers to Benefit from a New Premier Agreement for Cardiac Ultrasound Contrast Media. Nov 21, 2011 221
PharMerica Responds to K-V Pharmaceutical's Statements Regarding Makena[R] and Compounded 17P. Nov 18, 2011 991
Latest Mobile Testing Device Targets Drug Drivers. Nov 14, 2011 1267
Alere seeks U.S. artists to help Make Positive (+) More Positive. Nov 10, 2011 772
Global Bioimaging Technologies Industry. Company overview Nov 7, 2011 7471
Sigma-Aldrich Corporation to Present at Upcoming Investor Conferences. Conference news Nov 4, 2011 270
Global Liver Cancer Drugs industry. Oct 31, 2011 1710
China In Vitro Diagnostics Market Outlook to 2016. Oct 31, 2011 5181
Global HIV/AIDS Testing Industry. Oct 26, 2011 8231
Global Automated And Rapid Microbiological Tests Industry. Company overview Oct 25, 2011 7930
Lantheus Medical Imaging Awarded Three-Year Supplier Agreement with the Premier Healthcare Alliance for Radiopharmaceutical Products. Oct 24, 2011 753
Redwood Toxicology Laboratory Aligns "Bath Salt" Drug Testing With DEA's Proposed Ban. Oct 11, 2011 648
China In Vitro Diagnostics Market Outlook to 2016. Oct 5, 2011 5254
Global Cell/Tissue Culture Supplies Industry. Sep 29, 2011 5813
Lantheus Medical Imaging Announces Promotion of Cyrille Villeneuve to Chief Commercial Officer and Dana Washburn, M.D. to Chief Medical Officer. Company overview Sep 28, 2011 705
Life Technologies Signs Agreement with Quidel to Distribute and Commercialize Diagnostic Assays in Europe. Sep 22, 2011 793
Bristol-Myers Squibb and Saladax Biomedical Expand Collaboration for Diagnostic Assays for Alzheimer's Disease. Sep 20, 2011 707
Global High Throughput Screening (HTS) Industry. Sep 8, 2011 2646
Global Nuclear Medicine (Medical Isotopes/ Radioisotopes/ Radiopharmaceuticals) Market in PET/SPECT Imaging and Therapy - Competitive Landscape, Current trends and Forecasts (2010 - 2015). Sep 7, 2011 4313
Dendreon Announces Election of John H. Johnson to Board of Directors. Aug 22, 2011 520
Lantheus Medical Imaging to Host Second Quarter 2011 Conference Call on August 23, 2011 at 4:00 p.m. Eastern Time. Aug 16, 2011 343
Ramona M. Lloyd, Ph.D., RAC, Joins Omthera Pharmaceuticals as Vice President Regulatory Affairs. Jul 28, 2011 756
Lantheus Medical Imaging Announces Management Change. Company overview Jul 27, 2011 370
Lantheus Medical Imaging Announces Promotion of Jeffrey Young to Vice President, Finance. Company overview Jul 26, 2011 410
-JNJ-Ortho Clinical Diagnostics Launches Vitros 4600 Chemistry System For Mid- To High-Volume Laboratories. Jul 25, 2011 873
Thermo Fisher Scientific Signs Agreement to Make its Biomarker Assays Available on Alere Triage Systems. Company overview Jul 21, 2011 502
Sigma Life Science Launches CompoZr Targeted Integration Kit - mRosa26 for the Mouse Genome. Jul 19, 2011 886
GE Capital Agents $2.1 Billion in Credit Facilities for Alere Inc. Company overview Jul 7, 2011 407
Lantheus Medical Imaging Initiates Phase 3 Clinical Trial of Flurpiridaz F 18 for the Detection of Coronary Artery Disease. Jun 30, 2011 1638
Chinmax Disclaims Liability Following China SFDA's Confirmation that Inverness Medical Beijing is Suspected of Forging SFDA Verification Seal and Approval Date in Submission of Triage BNP Test Registration. Jun 21, 2011 365
Research and Markets: Clinical Diagnostics Automation - Global Strategic Business Report 2011. Jun 16, 2011 469
Reportlinker Adds Global Clinical Diagnostics Automation Industry. Jun 13, 2011 3899
Lantheus Medical Imaging to Present at Jefferies 2011 Global Healthcare Conference. Conference news Jun 2, 2011 285
Lantheus Medical Imaging to Present Data on Novel PET Cardiac and Heart Failure Imaging Agents at SNM 58th Annual Meeting. Jun 1, 2011 1754
ENZON Names Ana I. Stancic Chief Financial Officer. May 31, 2011 783
Global Cell/Tissue Culture Supplies Industry. May 31, 2011 5812
Daniel Lynch Joins Third Rock Ventures as Entrepreneur-in-Residence. May 24, 2011 618
Global Blood Gas And Electrolyte Analyzers Industry. May 19, 2011 8204
Global Angiongenesis Inhibitors and Stimulators Industry. May 19, 2011 5313
Cellectis bioresearch Appoints Wako as Exclusive Distributor of its Genome Customization Solutions in Japan. May 18, 2011 630
Lantheus Medical Imaging to Host First Quarter 2011 Conference Call on May 23, 2011 at 4:00 p.m. Eastern Time. May 18, 2011 342
Lantheus Medical Imaging Presents Phase 2 Study Results of PET Myocardial Perfusion Imaging with Flurpiridaz F 18 at ICNC10. May 17, 2011 1673
bluebird bio Adds Biotech Industry Veterans to Management Team and Board. May 16, 2011 888
Lantheus Medical Imaging to Present Phase 2 Data of PET Myocardial Perfusion Imaging with Flurpiridaz F 18 at the International Conference of Non-Invasive Cardiovascular Imaging. Conference news May 13, 2011 1428
Reportlinker Adds The Global Market for AIDS/HIV Testing and Treatment. May 12, 2011 3054
Research and Markets: Cardiovascular Disease Diagnostics - 2011 Global Strategic Business Report. May 11, 2011 526
Lantheus Medical Imaging Announces Completion of Exchange Offer for its 9.750% Senior Notes Due 2017. May 10, 2011 664
Reportlinker Adds Clinical Chemistry Reagents, Analyzers and Test Kits - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017. May 5, 2011 3452
Reportlinker Adds Hematology Reagents and Analyzers - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017. Apr 12, 2011 3553
Roche and Lonza enter into MycoTOOL Distribution Agreement for Rapid Mycoplasma Testing Solutions. Apr 11, 2011 691
Lantheus Medical Imaging Commences Exchange Offer. Apr 11, 2011 813
Beijing Chaoyang District Court Grants Investigation Letters Against Inverness Medical Beijing, A Subsidiary of Alere Inc. Letter to the editor Apr 11, 2011 369
Alere Earns NCQA Health Information Products Certification for Health Information Line. Apr 6, 2011 520
Circadian's Partner ImClone Systems Commences First Phase 1 Clinical Trial of VEGFR-3 Antibody IMC-3C5. Apr 6, 2011 1264
Research and Markets: Cholesterol & Other Cardiovascular Testing - 2011 Global Strategic Business Report. Apr 6, 2011 398
KellBenx Secures Exclusive Worldwide License With AdnaGen for Commercializing Patented Antibodies. Apr 6, 2011 422
Roche Diagnostics Announces the Appointment of Robert Yates as New Head of Roche Applied Science. Mar 31, 2011 283
Reportlinker Adds Medical Imaging Markets. Mar 31, 2011 6622
Can the USDA Guidelines Really Lead to Healthier Eating Habits? Mar 30, 2011 915
Research and Markets: Diabetes Diagnostics - 2011 Global Strategic Business Report. Mar 30, 2011 450
Reportlinker Adds Medical Imaging Markets. Mar 29, 2011 6614
Celebrity Chef Carla Hall Dishes Out Exclusive Recipes and Healthy Cooking Tips On Behalf of Alere Health at the 2011 World Health Care Congress. Recipe Mar 24, 2011 954
Lantheus Medical Imaging Completes Private Offering of $150 Million of 9.750% Senior Notes Due 2017. Mar 21, 2011 605
Reportlinker Adds Global Cardiovascular Disease Diagnostics Industry. Mar 21, 2011 7541
Reportlinker Adds Global Angiongenesis Inhibitors and Stimulators Industry. Mar 21, 2011 5275
Research Study Characterized Analytical Performance and Clinical Potential of Roche Flu Test. Mar 17, 2011 725
Lantheus Medical Imaging Announces Expiration of Consent Solicitation and Receipt of Requisite Consents. Mar 16, 2011 557
Lantheus Medical Imaging Announces Proposed Private Offering of $150 Million of Senior Unsecured Notes. Mar 16, 2011 667
Global HIV/AIDS Testing Industry. Mar 16, 2011 8261
Surveyed U.S. Oncologists Estimate That 67 Percent of Patients with Advanced Non-Small-Cell Lung Cancer Who Complete First-Line Induction Therapy Receive Maintenance Therapy. Mar 14, 2011 762
Lantheus Medical Imaging Receives Special Protocol Assessment Approval from FDA for Phase 3 Trial of Flurpiridaz F-18 for the Diagnosis of Coronary Artery Disease. Mar 11, 2011 1479
Lantheus Medical Imaging Commences Consent Solicitation. Mar 4, 2011 942
Research and Markets: Biotechnology Reagents - Global Strategic Business Report. Mar 2, 2011 461
Quidel Reports Fourth Quarter and Full Year 2010 Results. Financial report Feb 24, 2011 15724
Lantheus Medical Imaging Announces Completion of Exchange Offer for Its 9.750% Senior Notes Due 2017. Feb 3, 2011 517
President of Lilly Oncology Announces Resignation. Jan 25, 2011 425
LILLY (ELI) & COMPANY - President of Lilly Oncology Announces Resignation. Jan 25, 2011 410
Lantheus Medical Imaging Announces Promotion of Robert Gaffey to Chief Financial Officer. Jan 18, 2011 554
Quidel to Present at JP Morgan 29th Annual Healthcare Conference. Conference news Jan 7, 2011 344
Quidel Announces Pricing of Common Shares Offering. Jan 6, 2011 676
Lantheus Medical Imaging Extends Molybdenum-99 Contract with Nordion. Jan 5, 2011 788
Quidel Announces Proposed Common Shares Offering. Jan 5, 2011 693
Lantheus Medical Imaging Commences Exchange Offer. Dec 31, 2010 818
Tranzyme Pharma Appoints Pharmaceutical Industry Veteran John H. Johnson as Chairman of its Board of Directors. Dec 15, 2010 431
Reimbursement Rate Nearly Tripled for Cylex's ImmuKnow Assay. Dec 14, 2010 634
Research and Markets: North America In Vitro Diagnostics Market Outlook to 2016. Industry overview Dec 13, 2010 443
Lantheus Medical Imaging Announces FDA Accepts for Review DEFINITY[R] Supplemental New Drug Application for Use in Stress Echocardiography. Dec 13, 2010 1473
Reportlinker Adds North America In Vitro Diagnostics Market Outlook to 2016. Dec 8, 2010 5101
Research and Markets: Asia-Pacific In Vitro Diagnostics Market Outlook to 2016. Dec 7, 2010 614
Three Suppliers Selected to Participate in Premier Healthcare Alliance Comparative Effectiveness Research Program. Dec 7, 2010 1363
Lantheus Medical Imaging Announces First Commercial Production of Technelite[R] Generators from Low-Enriched Uranium-Produced Molybdenum-99. Company overview Dec 6, 2010 849
SaneVax Team Asks Senator Grassley to Expand NCI Ethics Investigation. Nov 29, 2010 501
Reportlinker Adds Asia-Pacific In Vitro Diagnostics Market Outlook to 2016. Nov 22, 2010 5134
NeoPharm, Inc. Completes Merger with Insys Therapeutics, Inc. Nov 9, 2010 868
Neogenix Oncology[R] Engages Consultants for Strategic Partnerships and Media Communications. Nov 4, 2010 798
Fitch Affirms Eli Lilly & Co, Inc.'s IDR at 'A+'; Outlook Negative. Nov 3, 2010 885
Research and Markets: Immunoassay Systems - Global Strategic Business Report 2010 Features a Six-Year Historic Analysis for the Market and Estimates Up To 2015. Nov 3, 2010 483
Ex ImClone CEO Waksal back to Biotech with Deal. Nov 1, 2010 327
NeoPharm, Inc. Announces Merger with Insys Therapeutics, Inc. Oct 29, 2010 1164
Quidel Reports Third Quarter 2010 Results. Financial report Oct 27, 2010 15993
Reportlinker Adds Global Automated And Rapid Microbiological Tests Industry. Company overview Oct 18, 2010 8042
Quidel to Hold Third Quarter 2010 Results Conference Call on October 27, 2010. Oct 13, 2010 358
Resverlogix Appoints Kenneth J. Zuerblis to Board of Directors. Sep 30, 2010 941
Quidel Announces FDA Clearance of Its QuickVue[R] RSV 10 Immunoassay Diagnostic Test. Sep 29, 2010 942
RegeneRx Appoints R. Don Elsey to Board of Directors. Sep 2, 2010 1251
Trading on their own: big companies are still the ones most likely to execute trades in-house, even though new technology has made it easier to set up a trading desk. Hintze, John Sep 1, 2010 2134
Quidel Announces FDA Clearance of Its RapidVue[R] hCG Pregnancy Lateral Flow Diagnostic Test. Aug 31, 2010 696
QUIDEL REPORTS 2ND QTR 2010 NET LOSS OF $2.5 MILLION. Financial report Aug 28, 2010 810
NeoPharm, Inc. Announces Second Quarter 2010 Financial Results. Financial report Aug 26, 2010 5075
Quidel to Present at Canaccord Genuity 30th Annual Growth Conference. Conference news Aug 4, 2010 342
Quidel to Present at Wedbush Life Sciences Best Ideas Management Access Conference. Conference news Jul 30, 2010 346
Quidel Reports Second Quarter 2010 Results. Financial report Jul 29, 2010 16607
Quidel Announces the Availability of Its QuickVue[R]+ Infectious Mononucleosis Lateral Flow Diagnostic Test. Jul 26, 2010 859
Lantheus Medical Imaging, Inc. Launches DEFINITY[R] Ultrasound Contrast Imaging Agent in India. Jul 15, 2010 1280
Quidel to Hold Second Quarter 2010 Results Conference Call on July 29, 2010. Jul 9, 2010 363
Molecular Templates and ImClone Systems Form Oncology Drug Discovery and Translation Research Collaboration. Jul 6, 2010 529
Diagnostic Hybrids Receives Approval from Chinese SFDA for D3[R] Ultra[TM] DFA Respiratory Virus Screening and ID Kit. Jul 1, 2010 730
Industry Veteran Douglas White Appointed Chief Executive Officer of OpGen. Jun 30, 2010 755
NEOPHARM REPORTS FIRST QTR 2010 RESULTS. Financial report Jun 29, 2010 523
Global Liver Cancer Drugs industry. Jun 28, 2010 1745
NeoPharm, Inc. Announces First Quarter 2010 Financial Results and Clinical Trial Update. Jun 11, 2010 974
CardioGenics Announces Retention of Redington, Inc. to Provide Investor Relations Services for the Company. May 20, 2010 533
Research and Markets: Liver Cancer Drugs - Global Strategic Business Report Profiles 40 Niche Players Including Bayer Schering AG and Bristol-Meyer Squibb. May 19, 2010 284
Reportlinker Adds Global Liver Cancer Drugs industry. May 18, 2010 1802
NeoPharm Announces FDA Grant of Orphan Drug Designation for IL13-PE38QQR for the Treatment of Idiopathic Pulmonary Fibrosis. May 17, 2010 589
Quidel Reports First Quarter 2010 Results. Financial report Apr 29, 2010 1085
NeoPharm Starts Enrolling Pancreatic Cancer Patients in Phase II Trial of LE-DT. Apr 20, 2010 617
Quidel to Hold First Quarter 2010 Results Conference Call on April 29, 2010. Apr 15, 2010 316
WPCS Receives $7.9 Million in New Contracts. Mar 30, 2010 447
NeoPharm, Inc. Announces Fourth Quarter And Full Year 2009 Financial Results. Financial report Mar 18, 2010 2056
NeoPharm Announces Orphan Drug Application Filing for IL13-PE38QQR for the Treatment of Idiopathic Pulmonary Fibrosis. Mar 10, 2010 661
BIOCIUS Life Sciences Extends Global Presence with Distribution Agreement for Japan. Mar 3, 2010 511
Quidel Corporation Completes Acquisition of Diagnostic Hybrids. Feb 19, 2010 797
Quidel Reports Fourth Quarter and Full Year 2009 Results. Feb 11, 2010 1486
Quidel to Hold Fourth Quarter and Full Year 2009 Results Conference Call on February 11, 2010. Jan 29, 2010 384
Cylex(TM) Awarded New CPT Code For Its ImmuKnow(R) Assay. Jan 12, 2010 589
Quidel Corporation Announces Definitive Agreement to Acquire Diagnostic Hybrids. Jan 11, 2010 1386
Quidel Authorizes Additional $25 Million under Stock Repurchase Program. Dec 8, 2009 745
NeoPharm, Inc. Announces Settlement of Dispute with Diosynth, RTP. Dec 3, 2009 587
NeoPharm Presents the Phase I Data for Patients with Metastatic Solid Tumors. Nov 17, 2009 776
Welch Allyn's John Moran Recognized at 2009 HIDA MedSurg Conference and Expo. Conference news Nov 5, 2009 591
NeoPharm Names Dr. Aquilur Rahman as President and CEO. Oct 29, 2009 724
NeoPharm Submits Application for a Multicenter, Open-Label, Phase II Study of LE-DT for Locally Advanced or Metastatic Pancreatic Cancer Patients as a Frontline Treatment. Oct 27, 2009 625
NeoPharm, Inc. Announces Third Quarter 2009 Financial Results and Clinical Trials Update. Oct 26, 2009 1914
Quidel Announces Launch of Their MicroVue[R] C5a EIA Kit for Research Use Only. Oct 16, 2009 978
Quidel Reports Third Quarter 2009 Results. Financial report Oct 16, 2009 1303
Hospitals, Healthcare Providers to Save with New Premier Agreements for Blood Bank Analyzers, Reagents, Consumables and Service. Oct 9, 2009 204
Quidel Corporation Announces Joint Development and Commercialization Agreement with BioHelix Corporation. Oct 6, 2009 849
New CEO bryant offers quick view of Quidel. DiRamio, Denise Oct 1, 2009 604
Quidel to Present at the William Blair & Company Emerging Growth Stock Conference. Conference news Sep 22, 2009 353
Quidel Issues Clarification Regarding Special 510(k) Clearance to Add 2009 H1N1 Influenza A Virus Reactivity Information to the QuickVue Influenza A+B Test Package Insert. Correction notice Sep 18, 2009 729
Quidel Obtains Special 510(k) Clearance to Add 2009 H1N1 Influenza A Virus Reactivity Information to the QuickVue Influenza A+B Test Package Insert. Sep 17, 2009 738
Cylex, Inc. Appoints Brad L. Stewart as Chief Executive Officer and Chairman of the Board. Sep 10, 2009 953
Quidel to Present at Investor Conferences in September. Conference news Sep 10, 2009 500
Quidel Anticipates Record Quarterly Results Driven by Strong Demand for Flu Tests. Financial report Sep 10, 2009 1086
Dyax Announces Developments in Licensing and Funded Research Program. Aug 26, 2009 1183
AMDL Inc. Announces Inauguration of AMDL Diagnostics, Inc. Aug 20, 2009 1204
AMDL Inc. Announces Second Quarter 2009 Financial Results. Aug 19, 2009 1859
AMDL Inc. Files Notification of Late Filing for Form 10-Q. Aug 14, 2009 419
Cempra Pharmaceuticals Announces Appointment of John H. Johnson to Board of Directors. Aug 12, 2009 651
Quidel Launches Flu Test Educational Programs for the Clinical Community. Aug 10, 2009 852
Quidel Announces Executive Appointments. Aug 6, 2009 879
Science park tenant arrives. Geiger, Daniel Jul 29, 2009 656
NeoPharm, Inc. Announces Second Quarter 2009 Financial Results and Clinical Trials Update. Jul 27, 2009 1983
AMDL Diagnostics Inc. Presenting at the AACC Annual Meeting and Clinical Lab Expo in Chicago, July 20-23, 2009. Jul 22, 2009 884
Quidel Reports Second Quarter 2009 Results. Financial report Jul 22, 2009 1275
ImClone Systems and Bristol-Myers Squibb Announce Revisions to ERBITUX[R] (cetuximab) U.S. Product Labeling for Metastatic Colorectal Cancer. Jul 20, 2009 1625
Quidel to Hold 2009 Second Quarter Conference Call on July 22, 2009. Jul 9, 2009 379
AMDL Inc. Introduces New Brand Name for Its DR-70 (FDP) In Vitro Diagnostic Cancer Test. Jul 8, 2009 816
Probiotics: not just any bacteria will do. Brief article Jul 1, 2009 191
Level 3 Expands Relationship with ImClone Systems. Jun 29, 2009 696
AMDL CEO Featured in CEOCFO Magazine; Details Progress on DR-70 International Commercialization Strategy & Confidence in FY2009 Financial Forecast. Jun 17, 2009 530
Quidel Corporation to Attend the Sixth Annual Craig-Hallum Institutional Investor Conference. Conference news Jun 10, 2009 308
Reportlinker Adds Global In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2015. Jun 3, 2009 4668
AMDL, Inc. Announces First Quarter 2009 Financial Results. May 15, 2009 1478
AMDL, Inc. Enters Into Distribution Agreements With GenWay Biotech, Inc. to Advance Commercialization of the DR-70 (FDP) Cancer Test in the US and Canada. May 13, 2009 818

Terms of use | Copyright © 2013 Farlex, Inc. | Feedback | For webmasters | Submit articles